Dunad Therapeutics’ Post

View organization page for Dunad Therapeutics, graphic

4,104 followers

Dunad Therapeutics is excited to participate in the inaugural Covalent Drug Discovery Summit 2023 in Boston this week, including a Panel Discussion led by Dr. Laura Akullian D'Agostino, VP Chemistry, featuring our CSO Dr. Ruben Tommasi. The session is “Identifying the Most Promising Hits to Advance Lead Optimization” - come and see us today at 2:15pm! https://lnkd.in/dAbnydns

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics